Haemonetics Corporation (HAE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for HAE. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 317 institutions reported holding HAE, with 49.6 million shares worth $3.7 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 5,909,258 | $443M | INCREASED |
| Vanguard | 5,020,033 | $377M | DECREASED |
| Neuberger Berman Group | 4,179,443 | $313M | INCREASED |
| AQR Capital Management | 2,266,489 | $165M | DECREASED |
| Ariel Investments | 2,060,966 | $155M | NEW |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Roy Galvin (EVP, Chief Commercial Officer) | TAX-W | 146 | $17K | 2026-10-30 |
Full institutional holdings, insider history, and congressional trades for Haemonetics Corporation on SentiSense.